SLC26A10 Inhibitors

Chemical inhibitors of SLC26A10 encompass a range of compounds that impede its anion transport function. DIDS, a known anion exchanger inhibitor, can directly target the anion exchange mechanism of SLC26A10, resulting in a decrease in its ability to transport anions across the cell membrane. This action is shared by CFTR(inh)-172 and GlyH-101, both of which are primarily CFTR inhibitors but can also inhibit SLC26A10 due to the structural and functional similarities they share with CFTR, specifically in regard to anion exchange. Similarly, NPPB, a chloride channel blocker, can bind to SLC26A10 and prevent the transport of chloride ions, which is a primary function of the protein. Tannic acid takes a more general approach by non-specifically binding to and precipitating proteins, including SLC26A10, thus impairing its function. Further, Niflumic acid and Flufenamic acid, known for their inhibitory action on various chloride channels, can prevent the movement of chloride ions by directly obstructing the ion pathways in SLC26A10. Diclofenac, though known as a nonsteroidal anti-inflammatory drug, can inhibit SLC26A10 by interfering with anion transport mechanisms, a secondary action that derives from its possible effects on membrane transporters. Indanyloxyacetic acid targets the chloride/bicarbonate exchanger activity, a crucial function of SLC26A10, thereby impeding its transport capabilities. Talniflumate, by modulating chloride channels, can disrupt the bicarbonate transport function of SLC26A10. Ethacrynic acid, although traditionally used for different purposes, can impede the chloride transport mechanisms that SLC26A10 facilitates. Lastly, Mefenamic acid can act as a blocker of chloride channels, thus interfering with the anion exchange capability of SLC26A10, leading to functional inhibition of the protein's anion transport abilities. Through these mechanisms, each compound contributes to the overall inhibition of SLC26A10's role in cellular anion exchange processes.